CheckMyRecalls

10,013 recalls · updated 20 Nov 2026

American Health Packaging recalls Buprenorphine Sublingual Tablets…

American Health Packaging recalls Buprenorphine Sublingual Tablets (C-III)

Read the official FDA notice

Published
9 Sept 2026
Units affected
10,953 cartons.
Agency
FDA
Country
United States

The hazard

Labeling: Label Mix-up

Classification: Class III — this product is unlikely to cause health problems but breaks FDA rules (for example labeling).

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Buprenorphine Sublingual Tablets (C-III), 2 mg, 30 Tablets (3x10), Rx only, Distributed by: American Health Packaging, Columbus, Ohio 43217, Carton NDC#: 60687-481-21, (Individual Dose NDC: 60687-481-11).

Brand / company
American Health Packaging
Codes / lots
Lot # 1030023, Exp Date: 06/30/2027.
Distribution
US Nationwide.
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 9 Sept 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.